Brookstone Capital Management’s SAB Biotherapeutics SABS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-2,176
| Closed | -$17.4K | – | 907 |
|
|
2023
Q3 | $17.4K | Hold |
2,176
| – | – | ﹤0.01% | 818 |
|
|
2023
Q2 | $18.6K | Hold |
2,176
| – | – | ﹤0.01% | 815 |
|
|
2023
Q1 | $16.8K | Hold |
2,176
| – | – | ﹤0.01% | 816 |
|
|
2022
Q4 | $13.3K | Buy |
2,176
+529
| +32% | +$3.23K | ﹤0.01% | 808 |
|
|
2022
Q3 | $13K | Sell |
1,647
-315
| -16% | -$2.49K | ﹤0.01% | 775 |
|
|
2022
Q2 | $24K | Buy |
+1,962
| New | +$24K | ﹤0.01% | 748 |
|